JP2024528284A5 - - Google Patents

Info

Publication number
JP2024528284A5
JP2024528284A5 JP2024507165A JP2024507165A JP2024528284A5 JP 2024528284 A5 JP2024528284 A5 JP 2024528284A5 JP 2024507165 A JP2024507165 A JP 2024507165A JP 2024507165 A JP2024507165 A JP 2024507165A JP 2024528284 A5 JP2024528284 A5 JP 2024528284A5
Authority
JP
Japan
Prior art keywords
mutant
nucleic acid
osteoporosis
acid molecule
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024507165A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024528284A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074307 external-priority patent/WO2023019067A1/en
Publication of JP2024528284A publication Critical patent/JP2024528284A/ja
Publication of JP2024528284A5 publication Critical patent/JP2024528284A5/ja
Pending legal-status Critical Current

Links

JP2024507165A 2021-08-07 2022-07-29 分化抗原群109(cd109)阻害剤で骨ミネラル密度低下を治療する方法 Pending JP2024528284A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163230707P 2021-08-07 2021-08-07
US63/230,707 2021-08-07
PCT/US2022/074307 WO2023019067A1 (en) 2021-08-07 2022-07-29 Methods of treating decreased bone mineral density with cluster of differentiation 109 (cd109) inhibitors

Publications (2)

Publication Number Publication Date
JP2024528284A JP2024528284A (ja) 2024-07-26
JP2024528284A5 true JP2024528284A5 (cg-RX-API-DMAC7.html) 2025-08-04

Family

ID=83004518

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024507165A Pending JP2024528284A (ja) 2021-08-07 2022-07-29 分化抗原群109(cd109)阻害剤で骨ミネラル密度低下を治療する方法

Country Status (9)

Country Link
US (3) US11891607B2 (cg-RX-API-DMAC7.html)
EP (1) EP4381066A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024528284A (cg-RX-API-DMAC7.html)
KR (1) KR20240046531A (cg-RX-API-DMAC7.html)
CN (1) CN118541481A (cg-RX-API-DMAC7.html)
AU (1) AU2022325199A1 (cg-RX-API-DMAC7.html)
CA (1) CA3227109A1 (cg-RX-API-DMAC7.html)
IL (1) IL310276A (cg-RX-API-DMAC7.html)
WO (1) WO2023019067A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024210666A1 (ko) 2023-04-07 2024-10-10 주식회사 케이티 전이중통신에서 하향링크 데이터 채널을 송수신하는 방법 및 장치

Similar Documents

Publication Publication Date Title
KR101770435B1 (ko) 자연 안티센스 전사체가 아포리포단백질-a1로 억제에 의해 아포리포단백-a1 관련된 질환의 치료
RU2551234C2 (ru) Лечение сиртуин 1 (sirt1)-связанных заболеваний путем ингибирования натурального антисмыслового транскрипта
JP5039172B2 (ja) Smad7に対するアンチセンスオリゴヌクレオチド(ODN)及びその医療分野での使用
JP2010534195A (ja) アルテミン及び関連するリガンドについてのポリペプチド及びポリヌクレオチド、並びにその使用方法
US20150291954A1 (en) Organic compositions to treat beta-catenin-related diseases
CN104684927B (zh) 用于治疗与herv-w包膜蛋白表达相关的疾病中的髓鞘再生阻断的化合物
WO2025112188A1 (zh) Zfp217基因在制备治疗骨质疏松的药物中的应用
JP2024524375A5 (cg-RX-API-DMAC7.html)
Zhang et al. ULK1 Suppresses Osteoclast Differentiation and Bone Resorption via Inhibiting Syk‐JNK Through DOK3
Li et al. Intra-articular injection of miRNA-1 agomir, a novel chemically modified miRNA agonists alleviates osteoarthritis (OA) progression by downregulating Indian hedgehog in rats
US10449200B2 (en) Combined inhibition of the vitamin D receptor and poly(ADP) ribose polymerase (PARP) in the treatment of cancer
JP2024541089A5 (cg-RX-API-DMAC7.html)
EP1578939A2 (en) Translational control by small, non-translatable rnas
WO2004016739A2 (en) Cell modulation using a cytoskeletal protein
JP2024524388A5 (cg-RX-API-DMAC7.html)
KR101121987B1 (ko) 파골세포 골흡수 억제 siRNA 발현 벡터 및 이를 이용한 유전자 치료제
JP6407912B2 (ja) ヘモグロビン(hbf/hbg)に対する天然アンチセンス転写物の抑制によるhbf/hbg関連疾患の治療
Duan et al. Pengcui Li, Yangyang Gao 2, 7, Raorao Zhou, Xianda Che, Hang Wang, Lingling Cong, Pinpin Jiang, Dan Liang, Penghua Li 3, Chunfang Wang 4, Wenjin Li 5, Shengbo Sang 6
Mitsutake et al. BRAF mediates RET/PTC-induced MAPK activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis
Li Overexpression of Wnt5a in Bone Marrow-Derived Macrophages Promotes Osteoarthritis Progression
CN119700934A (zh) Meis1在制备子宫内膜异位症治疗剂中的应用及其制备的治疗剂
CN108339119A (zh) miR-146a及其靶点在治疗骨关节炎中的应用
WO2017126655A1 (ja) 疼痛の予防または治療用医薬組成物およびRobo4を用いる疼痛抑制物質のスクリーニング方法
JP2024524526A5 (cg-RX-API-DMAC7.html)
CN120771279A (zh) Prmt6抑制剂在制备抗骨吸收产品中的用途